Production promoter, cosmetic composition, and method for producing cosmetic
A ceramide-based cosmetic composition in an aqueous dispersion form promotes hyaluronic acid synthase and fibroblast growth factors to improve skin health and reduce aging signs by enhancing moisturization and cell proliferation.
Patent Information
- Application Number
- JP2023078104
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-10
- Publication Date
- 2024-11-21
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing cosmetic formulations do not fully leverage the potential benefits of ceramides in promoting the production of hyaluronic acid synthase, MKI67, and fibroblast growth factors, which are crucial for skin health and anti-aging effects.
A cosmetic composition containing ceramide particles, preferably ceramide 2, in an aqueous dispersion form, applied to epidermal tissue to promote the production of hyaluronic acid synthase, MKI67, and fibroblast growth factors, particularly fibroblast growth factor 1 and 2, to enhance skin moisturization, cell proliferation, and reduce wrinkles and sagging.
The ceramide-based composition effectively enhances skin moisturization, promotes cell proliferation, and improves skin texture by increasing the production of target factors, thereby reducing signs of aging such as wrinkles and sagging.
Smart Images

Figure 2024162526000001
Abstract
Description
[Technical field]
[0001] The present disclosure relates to a production enhancer, a cosmetic composition, and a method for producing a cosmetic. [Background technology]
[0002] Ceramides are also contained in the human stratum corneum, and are known to play an important role in suppressing the evaporation of moisture from inside the skin and in ensuring the function of maintaining the flexibility and smooth appearance of the skin by retaining moisture itself. Therefore, various formulations containing ceramides are known (Patent Documents 1 to 3 and Non-Patent Document 1). [Prior art documents] [Patent documents]
[0003] [Patent Document 1] JP 2014-114235 A [Patent Document 2] JP 2012-41518 A [Patent Document 3] JP 2022-80694 A [Non-patent literature]
[0004] [Non-Patent Document 1] Bioscience, Biotechnology, and Biochemistry, 2022, Vol. 86, No. 9,1240-1246 Summary of the Invention [Problem to be solved by the invention]
[0005] Here, as described in, for example, Patent Documents 1 and 2, it is known that ceramides can prevent or improve skin aging symptoms such as wrinkles and sagging through the action of promoting the production of type I collagen, but according to the inventor's intensive research, it has been found that aqueous dispersions of ceramides have useful functions other than the action of promoting the production of type I collagen. In addition, although Non-Patent Document 1 evaluates the physiological action of a solution in which ceramide is dissolved in a mixed solvent of water and DMSO, there is no description regarding aqueous dispersions.
[0006] The present disclosure has been made in view of the above circumstances, and aims to provide a production promoter having a function particularly useful for the skin. It is also an object of the present disclosure to provide a cosmetic composition containing such a production promoter, and a method for producing a cosmetic. [Means for solving the problem]
[0007] The present disclosure includes the following embodiments. [1] A hyaluronic acid synthase production promoter comprising ceramide particles. [2] A production promoter according to [1], which is applied to epidermal tissue to promote the production of hyaluronic acid synthase in the epidermal tissue. [3] An MKI67 production promoter containing ceramide particles. [4] A production promoter according to [3], which is applied to epidermal tissue to promote the production of MKI67 in the epidermal tissue. [5] A fibroblast growth factor production promoter comprising ceramide particles. [6] [5] A production promoter for applying to epidermal tissue to promote the production of fibroblast growth factors in the epidermal tissue. [7] The production promoter according to [5] or [6], wherein the fibroblast growth factor is at least one of fibroblast growth factor 1 and fibroblast growth factor 2. [8] The production-promoting agent according to any one of [1] to [7], wherein the particles contain human ceramide. [9] The production-promoting agent according to any one of [1] to [8], wherein the particles contain only one or only two of ceramide 1, ceramide 2, and ceramide 3.
[10] The production enhancer according to any one of [1] to [9], wherein the particles have an average particle size of 200 nm or less.
[11] The production promoter according to any one of [1] to
[10] , further comprising a polyoxyethylene hydrogenated castor oil type nonionic surfactant.
[12] The production promoter according to any one of [1] to
[11] , which is an aqueous dispersion.
[13] A cosmetic composition comprising any one of the production enhancers according to [1] to
[12] .
[14] A method for producing a cosmetic, comprising the step of blending any one of the production enhancers [1] to
[12] with other raw materials. Effect of the Invention
[0008] According to the present disclosure, it is possible to provide a production promoter having a function particularly useful for the skin. In addition, according to the present disclosure, it is also possible to provide a cosmetic composition containing such a production promoter and a method for producing a cosmetic. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0009] The production enhancer according to this embodiment contains ceramide particles and can be used in at least one of the following (1) to (3). (1) Hyaluronic acid synthase (HAS) production promoter (2) MKI67 production promoter (3) Fibroblast growth factor (FGF) production promoter (1) The production promoter promotes the synthesis of hyaluronic acid, thereby improving the skin's moisturizing function. (2) The production promoter promotes skin turnover because MKI67 is an indicator of cell proliferation, and cell proliferation is actively carried out. (3) The production promoter promotes the proliferation of fibroblasts, thereby preventing or improving wrinkles, sagging, and the like. In addition to promoting the promotion of the production of the target factor, the production promoter may also suppress the production of compounds that inhibit the promotion of production (they may suppress the production of proteins that inhibit the promotion of production).
[0010] The production promoters (1) to (3) may be applied to epidermal tissue for use. That is, the production promoters (1) to (3) may be applied to epidermal tissue to promote the production of hyaluronic acid synthase, MKI67, or fibroblast growth factor in the epidermal tissue.
[0011] The hyaluronan synthase targeted by the production promoter of (1) may be hyaluronan synthase 3 (HAS3).
[0012] The fibroblast growth factor targeted by the production promoter of (3) may be fibroblast growth factor 1 (FGF1), fibroblast growth factor 2 (FGF2), or both.
[0013] <Ceramide particles> The production promoter of the present embodiment includes particles of ceramides. Examples of ceramides include ceramide, ceramide derivatives, and ceramide analogs. Ceramide is a compound having an amide bond between an amino group of sphingosine and a carboxyl group of a fatty acid. Examples of ceramide derivatives include sugar-modified ceramide. Examples of ceramides themselves include compounds having an amide bond between an amino group of phytosphingosine and a carboxyl group of a fatty acid, and derivatives thereof.
[0014] Ceramides may be naturally derived or synthetic. Naturally derived ceramides include those derived from animals and those extracted from plants such as wheat, rice, rice bran, soybeans, millet, and spinach.
[0015] The ceramides contained in the particles may be human ceramides. Human ceramides are ceramides mainly contained in the stratum corneum of human skin, and include ceramides 1 to 7. Since the amount of ceramide contained in the stratum corneum decreases due to aging or photoaging, the moisturizing function and skin barrier function can be improved by increasing the amount of ceramide in the stratum corneum. Therefore, the particles may contain only one of the seven types of ceramides 1 to 7, or may contain two or more types, or may contain only one or two types of ceramide 1, ceramide 2, and ceramide 3. The aqueous dispersion of this embodiment preferably contains ceramide 2, which is most abundant in the stratum corneum of human skin, and more preferably contains only ceramide 2.
[0016] The ceramide particles may contain components other than ceramides. The content of ceramides in the ceramide particles is preferably 70% by mass or more, more preferably 80% by mass or more, based on the total amount of the ceramide particles. The upper limit of the content of ceramides in the ceramide particles is not particularly limited, and may be substantially 100% by mass or 95% by mass based on the total amount of the ceramide particles.
[0017] From the viewpoint of enhancing storage stability, the ceramide particles may have an average particle diameter of 200 nm or less, 170 nm or less, or 160 nm or less. The lower limit of the average particle diameter of the ceramide particles is not particularly limited, but from the viewpoint of storage stability, the average particle diameter of the ceramide particles may be 1 nm or more, or 5 nm or more. The average particle diameter of the particles can be measured by dynamic light scattering, and a specific device can be Zetasizer Nano (manufactured by Malvern), etc. The average particle diameter of the particles can be a particle diameter (d50) that is 50% cumulative in the cumulative particle size distribution based on the number. Similarly, the polydispersity index of the ceramide particles can also be measured by dynamic light scattering.
[0018] The ceramide particles of the present embodiment may be contained in an aqueous dispersion. That is, the production enhancer of the present embodiment contains ceramide particles and an aqueous medium as a continuous phase.
[0019] The production promoter of this embodiment may satisfy at least one of the following conditions: when the aqueous dispersion is stored at 4°C for one year, the rate of change in the average particle size of the ceramide particles after storage is within 25% and the rate of change in the polydispersity index is within 30%, and the content of the fatty acid having 10 to 30 carbon atoms or a salt thereof in the aqueous dispersion for cosmetics is 1 mass% or less. When such an aqueous dispersion is blended into a cosmetic, it has good compatibility with various additives blended into the cosmetic, and can suppress the generation of aggregates in various cosmetic formulations, and can suppress the generation of aggregates even in a wide range of pH, temperature, etc. Therefore, the aqueous dispersion for cosmetics of this embodiment has excellent storage stability, blendability, and appearance of the aqueous dispersion. In addition, the aqueous dispersion of this embodiment tends to have excellent skin permeability.
[0020] As described above, the production promoter of the present embodiment is excellent as a component to be blended in cosmetics, and can be used as an aqueous dispersion for cosmetics. In addition, as described later, the aqueous dispersion of the present embodiment has an effect of promoting the production of type I procollagen, and therefore can also be used as a type I procollagen production promoter.
[0021] When the production promoter of this embodiment is stored in an aqueous dispersion at 4° C. for one year, the change rate of the average particle size of the ceramide particles after storage may be within 25%, and the change rate of the polydispersity index after storage may be within 30%. As for storage conditions, the production promoter may be stored in a dark place without vibrations, etc. The change rate of the average particle size of the ceramide particles after storage is calculated by dividing the absolute value of the difference between the average particle size at the end of storage and the average particle size at the start of storage by the average particle size at the start of storage.
[0022] Similarly, the rate of change in the polydispersity index of ceramide particles after storage is the absolute value of the difference between the polydispersity index at the end of storage and the polydispersity index at the start of storage divided by the polydispersity index at the start of storage.
[0023] The rate of change in the average particle size and polydispersity index of the ceramide particles after storage is expressed as a percentage.
[0024] The storage start point may be immediately after the production of the aqueous dispersion or any time point after the production. The storage end point may be one year, one year and two months, or one year and five months after the start of the storage.
[0025] The storage is carried out in an environment that can prevent evaporation of water from the aqueous dispersion. For example, the aqueous dispersion is preferably stored in a sealed container.
[0026] The rate of change in the average particle size of the ceramide particles after storage at 4° C. for one year is preferably 22%. The rate of change in the polydispersity of the ceramide particles after storage at 4° C. for one year is preferably 28%.
[0027] The polydispersity index of the ceramide particles in the aqueous dispersion may be 0.5 or less, or may be 0.4 or less.
[0028] Here, "within" refers to a range from 0 to a predetermined upper limit. The rate of change in the average particle size after storage may be substantially 0%, or may be greater than 0%, or may be 0.1% or more. The rate of change in the polydispersity index after storage may be substantially 0%, or may be greater than 0%, or may be 0.1% or more.
[0029] Furthermore, the particle size (d90) at cumulative 90% in the cumulative particle size distribution based on the number of particles of the ceramides is preferably 400 nm or less, more preferably 350 nm or less, and even more preferably 300 nm or less.
[0030] In addition, the polydispersity index of the ceramide particles is preferably 0.1 or more, more preferably 0.15 or more, and even more preferably 0.2 or more, from the viewpoint of reducing production costs. The polydispersity index of the ceramide particles may be 0.5 or less, or 0.4 or less, from the viewpoint of compatibility with cosmetics and improving appearance. The polydispersity index of the ceramide particles can be measured by the dynamic light scattering method described above.
[0031] The ceramide particles of this embodiment may be appropriately blended with lipids.
[0032] Examples of lipids include phospholipids, fatty acids having 10 to 30 carbon atoms, and salts thereof.
[0033] Examples of phospholipids include natural phospholipids such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, sphingomyelin, soybean lecithin, and egg yolk lecithin; hydrogenated phospholipids such as hydrogenated soybean phospholipid and hydrogenated egg yolk phospholipid in which the unsaturated carbon chains in natural phospholipids are saturated with hydrogen; and synthetic phospholipids such as dioleylphosphatidylcholine.
[0034] Examples of fatty acids having 10 to 30 carbon atoms or salts thereof include capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, 12-hydroxystearic acid, undecylenic acid, tallic acid, isostearic acid, arachidic acid, behenic acid, linoleic acid, α-linolenic acid, γ-linolenic acid, arachidonic acid, docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), erucic acid, and the like, and salts thereof. The content of fatty acids having 10 to 30 carbon atoms or salts thereof in the aqueous dispersion of this embodiment may be 1% by mass or less, 0.5% by mass or less, 0.1% by mass, or substantially 0% by mass (i.e., the aqueous dispersion may not contain fatty acids having 10 to 30 carbon atoms or salts thereof).
[0035] The lipids may be one or more kinds.
[0036] The ceramide particles may contain a surfactant. The surfactant is not particularly limited, and anionic surfactants, cationic surfactants, amphoteric surfactants, and nonionic surfactants that are generally used in cosmetics can be used. Examples of anionic surfactants include alkyl sulfates, polyoxyethylene alkyl sulfates, polyethylene glycol (PEG) fatty acid amide monoethanolamide (MEA) sulfates, alkyl methyl taurine salts, olefin sulfonates, alkyl sulfosuccinates, alkyl phosphate salts, fatty acid salts, acyl amino acid salts, alkyl lactates, and alkyl isethionates. Examples of cationic surfactants include lauryl trimethyl ammonium chloride, cetyl trimethyl ammonium chloride, stearyl trimethyl ammonium chloride, behenyl trimethyl ammonium chloride, cetyl trimethyl ammonium bromide, stearyl trimethyl ammonium bromide, dipolyoxyethylene oleyl methyl ammonium chloride, polyoxyethylene behenyl lylmethylene ammonium chloride, behenyl trimethyl ammonium methyl sulfate, stearyl hydroxypropyl trimethyl ammonium chloride, dicocoyl dimethyl ammonium chloride, dialkyl (C12-18) dimethyl ammonium chloride, dicetyl dimethyl ammonium chloride, distearyl dimethyl ammonium chloride, lanolin fatty acid aminopropyl dimethyl ammonium ethyl sulfate, dicocoyl ethyl hydroxyethyl ammonium methyl sulfate, coconut oil alkyl propylene glycol (PG) dimonium chloride phosphate, linoleic acid amidopropyl propylene glycol (PG) dimonium chloride phosphate, stearamidopropyl methylamine, dimethyl stearamine, polyoxyethylene (POE) coconut oil alkyl amine, and the like. Examples of the amphoteric surfactant include alkyl betaine type amphoteric surfactants such as lauryl dimethyl amino acetate betaine, amido betaine type amphoteric surfactants such as lauric acid amidopropyl betaine, carboic acid betaine type amphoteric surfactants such as hydroxyalkyl (C12-14) hydroxyethyl sarcosine, amido sulfobetaine type amphoteric surfactants such as lauric acid amidopropyl hydroxysulfobetaine, imidazolinium betaine type amphoteric surfactants such as sodium cocoamphodiacetate, propionic acid type amphoteric surfactants such as sodium lauraminopropionate, amine oxide type amphoteric surfactants such as lauryl dimethylamine oxide, and amino acid type surfactants such as N-[3-alkyl (12,14) oxy-2-hydroxypropyl]-L-arginine hydrochloride. Examples of nonionic surfactants include monoglycerin fatty acid ester type nonionic surfactants, polyglycerin fatty acid ester type nonionic surfactants, sorbitan and polyoxyethylene sorbitan type nonionic surfactants, polyoxyethylene sorbit tetraoleate type nonionic surfactants, polyoxyethylene hydrogenated castor oil type nonionic surfactants, pyrrolidone carboxylic acid (PCA) isostearate polyoxyethylene hydrogenated castor oil type nonionic surfactants, polyoxyethylene fatty acid type nonionic surfactants, polyoxyethylene fatty acid glycerin type nonionic surfactants, polyoxyethylene alkyl ether type nonionic surfactants, polyoxyethylene-polyoxypropylene alkyl ether type nonionic surfactants, polyoxyethylene-polyoxypropylene block polymer type nonionic surfactants, alkanolamide type nonionic surfactants, sucrose ester type nonionic surfactants, alkyl glycoside type nonionic surfactants, polyethylene glycol distearate (PEG) type nonionic surfactants, etc. The aqueous dispersion of this embodiment preferably contains a polyoxyethylene hydrogenated castor oil type nonionic surfactant. The polyoxyethylene hydrogenated castor oil type nonionic surfactant may be hydrogenated. The aqueous dispersion of the present embodiment may not contain a polyglycerol fatty acid ester type nonionic surfactant. The aqueous dispersion may contain only ceramides and a polyoxyethylene hydrogenated castor oil type nonionic surfactant as components other than water. These may be used alone or in combination with one or more of them. The amount of the surfactant in the aqueous dispersion may be 0.01 to 80 mass%, 0.1 to 50 mass%, 0.5 to 40 mass%, 3 to 30 mass%, or 5 to 35 mass% based on the total amount of the aqueous dispersion, from the viewpoints of skin irritation, compatibility, etc.
[0037] When the ceramide particles contain a polyoxyethylene hydrogenated castor oil type nonionic surfactant, the content of the polyoxyethylene hydrogenated castor oil type nonionic surfactant may be 0.01 to 80 mass%, 0.1 to 50 mass%, 0.5 to 40 mass%, 3 to 30 mass%, or 5 to 35 mass%. The content of the polyoxyethylene hydrogenated castor oil type nonionic surfactant may be the blending amount of the polyoxyethylene hydrogenated castor oil type nonionic surfactant relative to the total amount of the aqueous dispersion.
[0038] The content of ceramides in an aqueous dispersion containing ceramide particles is preferably 0.01 to 50% by mass, more preferably 0.05 to 30% by mass, and even more preferably 0.1 to 10% by mass, based on the total amount of the aqueous dispersion, from the viewpoint of blendability, etc. The content of ceramides in the aqueous dispersion may be 5% by mass or less, 3% by mass or less, 0.001 to 2% by mass, 0.005 to 1% by mass, or 0.01 to 0.5% by mass.
[0039] The lower limit of the content of ceramide 2 in the ceramide particles is not particularly limited, but from the viewpoint of improving the skin's moisturizing function and skin barrier property, it is preferably 70 mass % and more preferably 80 mass % relative to the total amount of the ceramide particles. The upper limit of the content of ceramide 2 in the ceramide particles is not particularly limited, but the ceramide particles may be composed of ceramide 2, or the ceramide particles may contain 99.5 mass % or less of ceramide.
[0040] The aqueous dispersion contains the above-mentioned ceramide particles and an aqueous medium as a continuous phase. The aqueous medium may be water itself, or may contain other components such as organic solvents and additives together with water. The additives may contain antioxidants and preservatives. Examples of antioxidants include ascorbic acid. Examples of preservatives include paraoxybenzoic acid esters, 1,2-hexanediol, citric acid, and phenoxyethanol.
[0041] The aqueous dispersion containing the ceramide particles of this embodiment can be produced by dispersing a raw material containing ceramides in an aqueous medium using a microfluidic device or the like. The raw material containing ceramides may be ceramides themselves, but naturally occurring ceramides may be naturally occurring extracts such as those extracted from bovine brain, wheat, rice, rice bran, soybeans, millet, spinach, and other plants. For example, the method described in Eur.J.Pharm.Biopharm.117,286-291 (2017) and the method for preparing an aqueous dispersion using a microfluidic device described in Eur.J.Pharm.Biopharm.63,128-133 (2006) can be used.
[0042] The aqueous dispersion of the present embodiment may contain particles other than ceramide particles (referred to as "other particles") as desired. The other particles may contain one or more types, and examples of such particles include vitamin E particles having an average particle size of 50 nm or less, gold particles having an average particle size of 200 nm or less, and curcuminoid particles having an average particle size of 200 nm or less. The vitamin E particles may contain components other than vitamin E, and preferably contain 70% by mass or more of vitamin E relative to the total amount of vitamin E particles. The gold particles may contain components other than gold, and preferably contain 70% by mass or more of gold relative to the total amount of gold particles. The curcuminoid particles may contain components other than curcuminoid, and preferably contain 70% by mass or more of curcuminoid relative to the total amount of curcuminoid particles.
[0043] <Cosmetic composition> The production promoter of the present embodiment can be made into a cosmetic composition by blending with a component (additive for cosmetic) that is usually blended in cosmetics. The content of the ceramide particles in the cosmetic composition is preferably 0.001% by mass or more, more preferably 0.01% by mass or more, and even more preferably 0.05% by mass or more, from the viewpoint of further increasing the storage stability of the ceramide particles in the cosmetic composition. In addition, from the viewpoint of ensuring the performance as a cosmetic, it is preferably 50% by mass or less. Examples of various components include those described below.
[0044] Examples of the cosmetic additives include oily components, powdery components, oil gelling agents, aqueous components, water-soluble polymers, ultraviolet absorbers, antioxidants, beauty ingredients, and preservatives. These additives can be appropriately blended to impart various effects.
[0045] Examples of oily components include hydrocarbons, fats and oils, waxes, ester oils, hardened oils, fatty acids, higher alcohols, silicone oils, lanolin derivatives, oily gelling agents, and the like, regardless of their origin (such as animal oils, vegetable oils, synthetic oils, etc.) and their properties (such as solid, semi-solid oil, liquid oil, volatile oil, etc.). Specifically, examples of the wax include paraffin wax, ceresin wax, microcrystalline wax, montan wax, Fischer-Tropsch wax, liquid paraffin, squalane, petrolatum, and other hydrocarbons, Japan wax, mink oil, olive oil, avocado oil, castor oil, macadamia nut oil, and other oils and fats, beeswax, carnauba wax, candelilla wax, and other waxes, pentaerythritol ester of rosin acid, jojoba oil, glyceryl tri-2-ethylhexanoate, isotridecyl isononanoate, cetyl 2-ethylhexanoate, isopropyl myristate, isopropyl palmitate, octyldodecyl myristate, glyceryl trioctanoate, polyglyceryl diisostearate, glyceryl triisostearate, diglyceryl triisostearate, polyglyceryl triisostearate, diisostearyl malate, neopentyl diethylhexanoate, fatty acids such as oleic acid, isostearic acid, stearic acid, lauric acid, myristic acid, behenic acid, etc.; higher alcohols such as stearyl alcohol, cetyl alcohol, lauryl alcohol, behenyl alcohol, etc.; silicone oils such as methylpolysiloxane, methylphenylpolysiloxane, trimethylsiloxysilicic acid, crosslinked polyether-modified methylpolysiloxane, methacryl-modified methylpolysiloxane, oleyl-modified methylpolysiloxane, polyvinylpyrrolidone-modified methylpolysiloxane, polyether-modified polysiloxane, etc.; lanolin derivatives such as lanolin, lanolin acetate, lanolin fatty acid isopropyl, lanolin alcohol, etc.; oil-based gelling agents such as aluminum isostearate, calcium stearate, 12-hydroxystearic acid, etc., and these may be used alone or in combination. Among these, low molecular weight ester oils such as glyceryl tri-2-ethylhexanoate, isononyl isononanoate, and neopentyl glycol diethylhexanoate are preferred from the viewpoints of spreadability and adhesion.
[0046] The powder component is not particularly limited by its shape (e.g., spherical, plate-like, needle-like, etc.), its particle size (e.g., aerosol-like, fine particles, pigment-grade, etc.), its particle structure (e.g., porous, non-porous, etc.), and examples of the powder component include inorganic powders, glittering powders, organic powders, pigment powders, metal powders, composite powders, etc.Specifically, white inorganic pigments such as titanium oxide, zinc oxide, cerium oxide, and barium sulfate, colored inorganic pigments such as iron oxide, carbon black, chromium oxide, chromium hydroxide, iron blue, and ultramarine, talc, muscovite, phlogopite, red mica, biotite, synthetic mica, sericite (sericite), synthetic sericite, kaolin, silicon carbide, bentonite, smectite, aluminum oxide, magnesium oxide, zirconium oxide, antimony oxide, diatomaceous earth, aluminum silicate, magnesium aluminum metasilicate, calcium silicate, barium silicate, and magnesium silicate. white body powders such as ammonium, calcium carbonate, magnesium carbonate, hydroxyapatite, boron nitride, and silica; lustrous powders such as titanium dioxide-coated mica, titanium dioxide-coated bismuth oxychloride, iron oxide-coated mica titanium, iron oxide mica, Prussian blue-treated mica titanium, carmine-treated mica titanium, bismuth oxychloride, and fish scale foil; polyamide resins, polyethylene resins, polyacrylic resins, polyester resins, fluorine-based resins, cellulose resins, polystyrene resins, copolymer resins such as styrene-acrylic copolymers, polypropylene resins, and silicone. Organic polymer resin powders such as corn resin and urethane resin; organic low molecular weight powders such as zinc stearate and N-acylysine; natural organic powders such as starch, silk powder and cellulose powder; organic pigment powders such as Red No. 201, Red No. 202, Red No. 205, Red No. 226, Red No. 228, Orange No. 203, Orange No. 204, Blue No. 404 and Yellow No. 401; organic pigment powders such as Red No. 3, Red No. 104, Red No. 106, Orange No. 205, Yellow No. 4, Yellow No. 5, Green No. 3 and Blue No. 1, such as zirconium, barium or aluminum lake, or further aluminum powder; Examples of such powders include metal powders such as gold powder and silver powder, composite powders such as fine particle titanium oxide coated mica titanium, fine particle zinc oxide coated mica titanium, barium sulfate coated mica titanium, titanium oxide silicon dioxide, zinc oxide silicon dioxide, and other glittering agents such as polyethylene terephthalate-aluminum-epoxy laminate powder, polyethylene terephthalate-polyolefin laminate film powder, and polyethylene terephthalate-polymethyl methacrylate laminate film powder, tar dyes, and natural dyes. One or more of these powders can be used, and further composite powders can be used.These powder components may be surface-treated with one or more of fluorine-based compounds, silicone-based compounds, metal soaps, lecithin, hydrogenated lecithin, collagen, hydrocarbons, higher fatty acids, higher alcohols, esters, wax quartz, waxes, surfactants, and the like.
[0047] Examples of the oil gelling agent include dextrin fatty acid esters, sucrose fatty acid esters, starch fatty acid esters, hydroxystearic acid, calcium stearate, hydrophobic fumed silica, and organically modified bentonite, and these may be used alone or in combination of two or more.
[0048] The aqueous component may be any component that is soluble in water or water, and examples of the aqueous component include, in addition to water, glycols such as propylene glycol, 1,3-butylene glycol, dipropylene glycol, and polyethylene glycol; glycerols such as glycerin, diglycerin, and polyglycerin; and plant extracts such as aloe vera, witch hazel, hamamelis, cucumber, lemon, lavender, and rose.
[0049] Examples of water-soluble polymers include natural polymers such as guar gum, sodium chondroitin sulfate, hyaluronic acid, gum arabic, sodium alginate, carrageenan, mucopolysaccharides, collagen, elastin, and keratin; semi-synthetic polymers such as methylcellulose, hydroxyethylcellulose, and carboxymethylcellulose; and synthetic polymers such as carboxyvinyl polymer, polyvinyl alcohol, polyvinylpyrrolidone, and sodium polyacrylate.
[0050] Examples of the ultraviolet absorbing agent include benzophenones, PABAs, cinnamic acids, salicylic acids, 4-tert-butyl-4'-methoxydibenzoylmethane, and oxybenzone.
[0051] Examples of the antioxidant include vitamin E such as tocopherol, ascorbic acid, and the like.
[0052] Examples of cosmetic ingredients include vitamins, proteins, anti-inflammatory agents, herbal medicines, etc.
[0053] Examples of preservatives include paraoxybenzoic acid esters and phenoxyethanol.
[0054] In addition, various other components than those described above may be blended within a range that does not impair the effects of the present disclosure, such as, for example, moisturizers, film-forming agents, anti-fading agents, defoamers, fragrances, fluorine-based oils such as perfluoropolyether, perfluorodecalin, and perfluorooctane; polyhydric alcohols, sugars, amino acids, various polymers, ethanol, thickeners, pH adjusters, blood circulation promoters, cooling agents, bactericides, and skin activators.
[0055] The cosmetic composition of the present embodiment is not particularly limited in its formulation or product form, and may be in the form of water-in-oil, oil-in-water, water dispersion, pressed, solid, powder, etc., and examples of the product form (cosmetics) include skin cosmetics such as face wash foam / cream, cleansing, massage cream, pack, lotion, milky lotion, cream, beauty essence, makeup base, sunscreen, etc., finishing cosmetics such as foundation, water whitening powder, eye shadow, eye liner, mascara, eyebrow, concealer, lipstick, lip balm, etc., hair cosmetics such as hair mist, shampoo, rinse, treatment, hair tonic, hair cream, pomade, tic, liquid hair styling product, setting lotion, hair spray, hair dye, etc., antiperspirants such as powder spray, roll-on, etc. Among these, solid preparations such as foundation and face powder are cosmetics that are likely to exhibit the effects of the present disclosure.
[0056] The method for producing the above-mentioned cosmetic composition or cosmetic is not particularly limited as long as it includes a step of blending the aqueous dispersion of the present embodiment with other raw materials (such as cosmetic additives) for producing the cosmetic. EXAMPLES
[0057] [Example 1] <Preparation of Aqueous Dispersion Containing Ceramide Particles> A transparent aqueous dispersion containing ceramide 2 particles was obtained by dispersing ceramide 2 (trade name: Ceramide TIC-001, manufactured by Takasago International Corporation) in an aqueous solution containing a surfactant by a known method for preparing an aqueous dispersion using a microfluidic device. The average particle size (number basis) of the ceramide 2 particles in the obtained aqueous dispersion was measured using a dynamic light scattering measuring device (trade name: Zetasizer Nano, manufactured by Malvern Corporation), and was found to be 153.8 nm and the polydispersity index was 0.383. The measurement by the dynamic light scattering method was performed under the experimental conditions of refractive index of the dispersion medium = 1.33, refractive index of the sample = 1.46, and viscosity (cP) of the sample = 0.89. The blending amount of each component of the above aqueous dispersion was 0.13 mass% of ceramide 2, 18 mass% of PEG-80 hydrogenated castor oil (nonionic surfactant), and the remaining amount was water.
[0058] <Functional evaluation using a three-dimensional skin model> The physiological function of ceramide aqueous dispersions was evaluated using T-skin (Nicoderm Research), a full-thickness human skin model. T-skin Culture Medium (Nicoderm Research) was added to a 6-well Cell Culture Plate (GREINER BIO-ONE) at 2 mL / well. T-skin delivered by Nicoderm Research was transferred to a 6-well Multiwell Cell Culture Plate containing T-skin Culture Medium and cultured for 24 hours at 37°C and 5% CO2 by volume. After 24 hours of culture, 1.13 mL / well (1 cm of the surface area of T-skin) was added to the epidermis of the T-skin. 2Phosphate buffer (D-PBS(-), Fujifilm Wako Pure Chemical Industries, Ltd.) and the above-mentioned aqueous dispersion of ceramides were added to make a total volume of 1 mL per 100 ml of culture medium, and the medium was cultured for 8 hours under conditions of 37°C and 5% CO2 by volume. After the culture was completed, the T-skin was collected, and the epidermis, dermis, and film layer of the T-skin were each peeled off using tweezers. After RNA stabilization treatment of only the epidermis portion using RNAlater (ThermoFisher), total RNA was extracted using the miRNeasymini kit (Qiagen) according to the method recommended by Qiagen. Using an ultra-microspectrophotometer NanoDrop One (ThermoFisher) and a bioanalyzer (Agilent), the RNA concentration, purity (260 / 280, 260 / 230), and the RIN value, which is an index of the degree of RNA decomposition, were measured, and after confirming that 260 / 280 and 260 / 280 were 1.7 or more and the RIN value was 7 or more, cDNA synthesis was performed from each total RNA using ReverTra Ace (registered trademark) qPCR RT MasterMix (TOYOBO). The cDNA synthesis conditions were performed according to the recommended protocol disclosed by TOYOBO. Quantitative PCR was performed using QIAcuity One (Qiagen) and QIAcuity probe PCR kit (Qiagen) according to the protocol recommended by Qiagen. In addition, the quantitative PCR used the following Tagman probe purchased from ThermoFisher, and the experiment was performed in duplicate. GAPDH (glyceraldehyde-3-phosphate dehydrogenase) (Hs99999905 m1) HAS3 (Hs00193436 m1) ·MKI67(Hs04260396 g1) ·FGF1(Hs01092738 m1) · FGF2 (Hs00266645 m1) Using GAPDH as an endogenous control, the copy number of each gene was corrected according to the following formula, and then the relative expression level of each gene in the aqueous dispersion of ceramides was calculated with the phosphate buffer solution added group set at 1. The results are shown in Table 1.
[0059] [Table 1]
[0060] The above results indicate that aqueous dispersions of ceramides are expected to have the effect of improving skin moisturizing due to increased gene expression of hyaluronic acid synthase (HAS3), to promote epidermal turnover due to increased gene expression of MKI67, a marker for proliferating cells, and to improve wrinkles by promoting the proliferation of dermal fibroblasts due to increased gene expression of fibroblast growth factors FGF1 and FGF2.
Claims
1. A hyaluronic acid synthase production promoter comprising ceramide particles.
2. The production promoter according to claim 1 , which is applied to epidermal tissue to promote the production of hyaluronic acid synthase in the epidermal tissue.
3. An agent for promoting MKI67 production, comprising particles of ceramides.
4. The production promoter according to claim 3, which is applied to epidermal tissue to promote the production of MKI67 in the epidermal tissue.
5. A fibroblast growth factor production promoter comprising ceramide particles.
6. The production-promoting agent according to claim 5 , which is applied to epidermal tissue to promote the production of fibroblast growth factors in said epidermal tissue.
7. The production promoter according to claim 5 , wherein the fibroblast growth factor is at least one of fibroblast growth factor 1 and fibroblast growth factor 2.
8. The production-promoting agent according to any one of claims 1 to 7, wherein the particles contain human ceramide.
9. The production-promoting agent according to any one of claims 1 to 7, wherein the particles contain only one or only two of ceramide 1, ceramide 2 and ceramide 3.
10. The production-promoting agent according to any one of claims 1 to 7, wherein the particles have an average particle size of 200 nm or less.
11. The production-promoting agent according to any one of claims 1 to 7, further comprising a polyoxyethylene hydrogenated castor oil type nonionic surfactant.
12. The production-promoting agent according to any one of claims 1 to 7, which is in the form of an aqueous dispersion.
13. A cosmetic composition comprising the production enhancer according to any one of claims 1 to 7.
14. A method for producing a cosmetic, comprising a step of blending the production enhancer according to any one of claims 1 to 7 with other raw materials.
Citation Information
Patent Citations
Sphingolipid and method for obtaining sphingolipid
JP2012041518A
Melanogenesis inhibitor and collagen production promoter
JP2014114235A
Growth factor gene expression promoter
JP2022080694A
